Abstract
Assessment of Measures to Reduce Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab in the GREEN Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have